Mark A. Nagy

Green chemistry tools to influence a medicinal chemistry and research chemistry based organisation

Kim Alfonsi, Juan Colberg, Peter J. Dunn et al. · Green Chemistry · 2007 · 1.1K citations

Engineering, Education Tools, Environmental Impact Assessment +18

Discovery of CRBN E3 Ligase Modulator CC-92480 for the Treatment of Relapsed and Refractory Multiple Myeloma

Joshua D. Hansen, Matthew Correa, Mark A. Nagy et al. · Journal of Medicinal Chemistry · 2020 · 204 citations · Full text

Hematological Malignancy, Novel Therapy, Medicine +15

CC-90009: A Cereblon E3 Ligase Modulating Drug That Promotes Selective Degradation of GSPT1 for the Treatment of Acute Myeloid Leukemia

Joshua D. Hansen, Matthew Correa, Matt Alexander et al. · Journal of Medicinal Chemistry · 2021 · 138 citations · Full text

Mixed-phenotype Acute Leukemia, Immunology, Cell Death +17

The Discovery of a Dual TTK Protein Kinase/CDC2-Like Kinase (CLK2) Inhibitor for the Treatment of Triple Negative Breast Cancer Initiated from a Phenotypic Screen

Jennifer R. Riggs, Mark A. Nagy, Jan Elsner et al. · Journal of Medicinal Chemistry · 2017 · 59 citations · Full text

Breast Oncology, Pharmaceutical Chemistry, Tumor Biology +18

Discovery of the c-Jun N-Terminal Kinase Inhibitor <b>CC-90001</b>

Mark A. Nagy, Robert Hilgraf, Deborah S. Mortensen et al. · Journal of Medicinal Chemistry · 2021 · 35 citations · Full text